welcome to summit

Summit is an Oxford, UK based drug discovery company with a portfolio of partner funded drug programmes and an innovative Seglin™ technology platform for the discovery of new medicines.

our Programms 03
image

Visit our programmes section to find out more about our research activities and drug programmes.

Seglin technology drug discovery platform
Seglin

Our recently updated Seglin section provides more information about this innovative drug discovery platform.

promobox01_for_investors
Investors thumbs

Visit our Investor Relations section for the latest financial reports, regulatory news and share information.

current share price:

LSE (SUMM): 4.88p +0.00p
at closed   28 Jan 2012
15 minute delayed share price from London Stock Exchange provided by Hemscott Group Limited

latest news: